Moclobemide in pregnancy

We report on the case of female patient with chronic dysthymia, who took moclobemide at 300 mg/day throughout her first pregnancy. The course of pregnancy was healthy, and natural delivery was uneventful. The psychomotoric and somatic development of the child within first 14 months of life has been normal.

References

• 1 Bazire S. Psychotropic drug directory. Dinton: Mark Alien Publishing Ltd 1999
• 2 Gracious B L, Wisner K L. Phenelzine use throughout pregnancy and the puerperium: case report, review of the literature, and management recommendations.  Depression and Anxiety. 1997;  6 124-128
• 3 McElhatton P R, Garbis H M, Elefant E, Vial T, Bellemin B, Mastroiacovo P. et al . The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS).  Reprod Toxicol. 1996;  10 285-294
• 4 Oie S, Guentert T W, Tolentino L, Hermodsson G. Pharmacokinetics of moclobemide in male, virgin female, pregnant and nursing rats.  J Pharm Pharmacol. 1992;  44 413-418
• 5 Pavy T J, Kliffer A P, Douglas M J. Anaesthetic management of labour and delivery in a woman taking long-term MAOI.  Can J Anaesth. 1995;  42 618-620
• 6 Poulson E, Robson J M. Effect of phenelzine and some related compounds on pregnancy and on sexual development.  J Endocrin. 1964;  30 205-215
• 7 Versiani M. Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.  J Affect Disord. 1998;  51 323-332
• 8 Vitalis T, Cases O, Callebert J, Launay J M, Price D J, Self I. et al . Effect of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: determination of a sensitive developmental period.  J Corn Neurol. 1998;  393 169-184
• 9 Wisner K L, Gelenberg A L, Leonard H, Zarin D, Frank E. Pharmacologic treatment of depression during pregnancy.  J Am Med. Assoc. 1999;  282 1264-1269